About the meeting
Organised by Dr Barbara Tanos, this one-day meeting brings together researchers, charities and industry to discuss emerging directions in polycystic kidney disease (PKD). The programme spans disease mechanisms, advanced experimental models, functional genomics, biomarker discovery, clinical trials and therapeutic development.
Programme highlights
- Welcome from Dr Barbara Tanos and opening remarks from Dr Kerstin Kinkelin, Kidney Research UK.
- Session 1: genes, advanced therapies, organ-chip models, regulatory genomics and urinary single-cell biomarker discovery.
- Keynote: From mechanism to therapeutic development: the LoAc approach in ADPKD, Dr David Henderson, Mironid.
- Lunch, networking and poster session.
- Session 2: ciliopathies, cystic kidney disease models, cilia biology, clinical trials and genomics in ADPKD.
- Round-table discussion.
- Final remarks and close.